Published in Am J Pathol on November 01, 1976
Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy. Am J Pathol (2010) 1.19
Adenosine release from stimulated mast cells. Proc Natl Acad Sci U S A (1984) 1.11
Effects of staphylococcal enterotoxin B on rodent mast cells. Infect Immun (1992) 0.98
Selective release of excreted DNA sequences from phytohemagglutinin-stimulated human peripheral blood lymphocytes. Effects of trypsin and divalent cations. J Clin Invest (1978) 0.95
Sodium fluoride evoked histamine release from mast cells. A study of cyclic AMP levels and effects of catecholamines. Agents Actions (1983) 0.94
Immunologic and nonimmunologic generation of superoxide from mast cells and basophils. J Clin Invest (1978) 0.88
The lectin ArtinM induces recruitment of rat mast cells from the bone marrow to the peritoneal cavity. PLoS One (2010) 0.81
Effect of cholera toxin on histamine release from bone marrow-derived mouse mast cells. Proc Natl Acad Sci U S A (1988) 0.77
Surface histamine receptors in rat peritoneal mast cells. Separation of receptor-bearing cells via binding to a histamine-protein conjugate, Cell-ect. Agents Actions (1984) 0.75
Stimulus-secretion coupling: the concept and clues from chromaffin and other cells. Br J Pharmacol (1968) 7.91
A23187: a divalent cation ionophore. J Biol Chem (1972) 6.97
The role of calcium in the release of neurotransmitter substances and hormones. Pharmacol Rev (1970) 5.55
Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science (1968) 4.38
The interaction of cyclic nucleotides and calcium in the control of cellular activity. Adv Cyclic Nucleotide Res (1975) 3.38
Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. J Exp Med (1972) 3.31
Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01
Pharmacologic control of allergic histamine release in vitro: evidence for an inhibitory role of 3',5'-adenosine monophosphate in human leukocytes. J Immunol (1972) 2.70
Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology (1975) 2.62
Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP. Fed Proc (1972) 2.55
Inhibition of histamine release by histamine controlled by H2 receptor. Nature (1973) 2.19
Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells. J Immunol (1974) 2.16
Modulation of cyclic AMP in purified rat mast cells. I. Responses to pharmacologic, metabolic, and physical stimuli. J Immunol (1975) 2.07
Role of contractile microfilaments in the release of histamine from mast cells. Nature (1972) 1.99
Histamine release from human leukocytes: studies with deuterium oxide, colchicine, and cytochalasin B. J Clin Invest (1972) 1.98
The immediate allergic response: in vitro separation of antigen activation, decay and histamine release. J Immunol (1971) 1.93
In vitro studies of reversed anaphylaxis with rat cells. Immunology (1963) 1.87
In vivo and in vitro production of a slow reacting substance in the rat upon treatment with calcium ionophores. J Immunol (1974) 1.84
Kinetics of transport of divalent cations across sarcoplasmic reticulum vesicles induced by ionophores. Biochem Biophys Res Commun (1972) 1.83
Enzyme secretion in mouse pancreas mediated by adenosine-3'5'-cyclic phosphate and inhibited by adenosine-3'-phosphate. Proc Natl Acad Sci U S A (1968) 1.77
Effects of dibutyryl-3',5'-cyclic adenosine monophosphage, phosphodiesterase inhibitors and prostaglandin E1 on compound 48-80-induced histamine release from rat peritoneal mast cells in vitro. Biochem Pharmacol (1971) 1.76
Inhibition of the anaphylactic mechanism by sympathomimetic amines. Int Arch Allergy Appl Immunol (1971) 1.74
The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release. J Immunol (1971) 1.73
Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest (1974) 1.68
Mechanisms of passive sensitization. IV. Dissociation of IgE molecules from basophil receptors at acid pH. J Immunol (1974) 1.62
Binding parameters of the interaction between rat IgE and rat mast cell receptors. J Immunol (1975) 1.55
Modulation of cyclic AMP in purified rat mast cells. II. Studies on the relationship between intracellular cyclic AMP concentrations and histamine release. J Immunol (1975) 1.52
THE ROLE OF A CHYMOTRYPSIN-LIKE ENZYME IN HISTAMINE RELEASE FROM RAT MAST CELLS. Immunology (1963) 1.49
Surface IgE on human basophils during histamine release. J Exp Med (1973) 1.48
Formation of slow-reacting substance of anaphylaxis in human lung tissue and cells before release. J Exp Med (1974) 1.44
Cyclic AMP and platelet function. N Engl J Med (1972) 1.42
Energy production in rat mast cells and its role for histamine release. Int Arch Allergy Appl Immunol (1975) 1.40
Concanavalin A, a model "antigen" for the in vitro detection of cell-bound reaginic antibody in the rat. Clin Exp Immunol (1973) 1.38
Adenosine release from fat cells: effect on cyclic AMP levels and hormone actions. Adv Cyclic Nucleotide Res (1975) 1.36
Proceedings: Mast cell secretion (histamine release) induced by 48-80: calcium-dependent exocytosis inhibited strongly by cytochalasin only when glycolysis is rate-limiting. J Physiol (1973) 1.36
Time course of anaphylactic histamine release and morphological changes in rat peritoneal mast cells. Acta Physiol Scand (1970) 1.34
Stimulation and inhibition of histamine release from isolated rat mast cells. Dual effects of the ionophore A23187. Int Arch Allergy Appl Immunol (1975) 1.31
Release of adenosine and lack of release of ATP from contracting skeletal muscle. Pflugers Arch (1975) 1.26
The requirement for sensitized lymphocytes in one form of antigen-induced histamine release from rabbit platelets. Proc Natl Acad Sci U S A (1968) 1.23
The tumor-promoter phorbol ester (12-O-tetradecanoyl-phorbol-13-acetate), a potent aggregating agent for blood platelets. J Cell Biol (1974) 1.21
Regulation of nucleoside cyclic 3':5'-monophosphate phosphodiesterase activity from rat brain by a modulator and Ca2+. Proc Natl Acad Sci U S A (1973) 1.20
Mode of storage of histamine in mast cells. Acta Physiol Scand (1967) 1.17
The activation of adenylate cyclase. II. The postulated presence of (A) adenylate cyclase in a phospho (inhibited) form (B) a dephospho (activated) form with a cyclic adenylate stimulated membrane protein kinase. Biochem Biophys Res Commun (1973) 1.17
Inhibition of the release of histamine from rat mast cells: the effect of cold and adrenergic drugs on release of histamine by compound 48-80 and antigen. J Pharmacol Exp Ther (1970) 1.16
Concanavalin A-induced histamine release from normal rat mast cells. J Immunol (1975) 1.15
Heavy water enhances IgE-mediated histamine release from human leukocytes: evidence for microtubule involvement.. 1. Proc Soc Exp Biol Med (1972) 1.15
Basophil activation by concanavalin A: characteristics of the reaction. J Immunol (1974) 1.13
A method for detecting intracellular cyclic adenosine monophosphate by immunofluorescence. J Histochem Cytochem (1972) 1.12
Localization of calcium pump activity in smooth muscle. Science (1973) 1.11
The effect of thiols on the immunologic release of slow reacting substance of anaphylaxis. II. Other in vitro and in vivo models. J Immunol (1976) 1.08
Ionophore mediated equilibration of calcium ion gradients in fragmented-sarcoplasmic reticulum. FEBS Lett (1972) 1.07
Selective release of histamine from rat mast cells by several drugs. J Pharmacol Exp Ther (1970) 1.07
Cyclic AMP and the immune response;. Adv Cyclic Nucleotide Res (1974) 1.07
Immunologic properties of mast cells from rats infected with Nippostrongylus brasiliensis. J Immunol (1975) 1.02
Dependence of histamine release from rat mast cells on adenosine triphosphate. Naunyn Schmiedebergs Arch Pharmacol (1972) 0.96
Cyclic 3',5'-adenosine monophosphate in isolated bone cells. II. Responses to adenosine and parathyroid hormone. Endocrinology (1974) 0.96
Regulation of coronary blood flow. Adv Cardiol (1974) 0.94
The role of Ca-2+ and cyclic adenosine 3':5'-monophosphate in insulin release induced in vitro by the divalent cation ionophore A23187. J Biol Chem (1975) 0.93
Cyclic AMP content and histamine release in rat mast cells. J Immunol (1974) 0.93
Histamine release from rat mast cells by dextran: effects of adrenergic agents, theophylline and other drugs. Proc Soc Exp Biol Med (1972) 0.92
The activation of adenylate cyclase. I. A postulated mechanism for fluoride and hormone activation of adenylate cyclase. Mol Cell Biochem (1973) 0.88
Characteristics of the hormonal induced cyclic adenosine 3',5'-monophosphate response in the rat and guinea pig lung in vitro. Biochim Biophys Acta (1971) 0.88
Release of histamine from hamster mast cells by concanavalin A and phytohemagglutinin. Infect Immun (1974) 0.87
Cyclic nucleotides and modulation of effector systems of inflammation. Biochem Pharmacol (1974) 0.87
EFFECTS OF ADRENOTROPIC DRUGS ON THE RELEASE OF HISTAMINE IN THE ANAPHYLACTIC REACTION OF THE ISOLATED GUINEA PIG HEART. Life Sci (1964) 0.85
Granule alteration and vacuole formation, two primary structural features of the histamine release process in mast cells. Experientia (1973) 0.84
Effect of anaphylaxis and histamine, pyrilamine and burimamide on levels of cyclic AMP and cyclic GMP in guinea-pig lung. Res Commun Chem Pathol Pharmacol (1974) 0.84
Dissociation of the immunologic release of histamine and slow reacting substance of anaphylaxis from human lung using cytochalasins A and B-1. J Immunol (1975) 0.82
Cyclic AMP phosphodiesterase activation by the histamine releasing agent, compound 48-80. Biochem Biophys Res Commun (1973) 0.80
Influence of adenosine and lowered cerebral blood flow on the cerebrovascular effects of theophylline. Eur J Pharmacol (1975) 0.80
Effects of a beta-adrenergic blocking agent and isopropylmethoxamine on the release of histamine from guinea pig lung during anaphylaxis in vitro. Biochem Pharmacol (1965) 0.79
Structural changes of isolated rat peritoneal mast cells induced by adenosine triphosphate and adenosine diphosphate. J Histochem Cytochem (1968) 0.78
The nature of antigen--antibody complexes initiating PCA reactions in the guinea pig. Proc Soc Exp Biol Med (1970) 0.76
Degranulation and histamine release in focal antigen-antibody reaction by means of microelectrophoresis in a single rat mesentery mast cell. Jpn J Pharmacol (1972) 0.76
Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem (1972) 8.24
EXCITATION ENERGY TRANSFER AND THE QUANTITATIVE STUDY OF THE ANTIBODY HAPTEN REACTION. Proc Natl Acad Sci U S A (1960) 4.43
Orbital venous anomalies. Ophthalmology (1997) 3.25
Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01
Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity (1997) 2.72
Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation. J Clin Invest (1971) 2.61
Nontraumatic subperiosteal orbital hemorrhage. Ophthalmology (2001) 2.55
Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. J Clin Invest (1973) 2.42
Biphasic and protracted anaphylaxis. J Allergy Clin Immunol (1986) 2.36
Illness behavior and the sick role in chronic disease. The case of multiple sclerosis. Soc Sci Med (1982) 2.25
Precision and accuracy of commercial laboratories' ability to classify positive and/or negative allergen-specific IgE results. Ann Allergy Asthma Immunol (2001) 2.23
The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol Rev (1996) 2.18
The measurement of digitoxin in human serum by radioimmunoassay. J Clin Invest (1968) 2.16
Reactions following intravenous fluorescein. Am J Ophthalmol (1971) 2.13
Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma. J Clin Invest (1973) 2.09
Biomechanics of baseball pitching. A preliminary report. Am J Sports Med (1985) 2.08
Modulation of cyclic AMP in purified rat mast cells. I. Responses to pharmacologic, metabolic, and physical stimuli. J Immunol (1975) 2.07
Potentiation of mast cell mediator release by adenosine. J Immunol (1978) 2.05
Radioimmunoassay for prostaglandins. Science (1971) 1.99
Disability resulting from occupational low back pain. Part I: What do we know about primary prevention? A review of the scientific evidence on prevention before disability begins. Spine (Phila Pa 1976) (1996) 1.97
Cytokinin Biochemistry in Relation to Leaf Senescence: IV. Cytokinin Metabolism in Soybean Explants. Plant Physiol (1988) 1.87
Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sci U S A (1977) 1.86
Quantitation of cytokinins in biological samples using antibodies against zeatin riboside. Plant Physiol (1984) 1.84
Determinants of duration of disability and return-to-work after work-related injury and illness: challenges for future research. Am J Ind Med (2001) 1.79
Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids. J Clin Invest (1979) 1.77
Disability resulting from occupational low back pain. Part II: What do we know about secondary prevention? A review of the scientific evidence on prevention after disability begins. Spine (Phila Pa 1976) (1996) 1.76
Transfection of the malaria parasite and expression of firefly luciferase. Proc Natl Acad Sci U S A (1993) 1.70
Lymphocyte activation. Prog Allergy (1976) 1.69
Prostaglandins, macrophages, and immunity. J Immunol (1980) 1.69
Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int Immunol (1996) 1.69
Preparation and characterization, using high-performance liquid chromatography, of an enzyme forming glucosides of cytokinins. Biochim Biophys Acta (1979) 1.61
Isolation of pure human peripheral blood T-lymphocytes using nylon wool columns. Immunol Commun (1972) 1.58
Release of slow reacting substance (SRS) from rat basophilic leukemia (RBL-1) cells. J Immunol (1977) 1.58
Morphine: radioimmunoassay. Science (1970) 1.56
Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils. J Immunol (1980) 1.55
Activation of phospholipid metabolism during mediator release from stimulated rat mast cells. J Immunol (1979) 1.54
Modulation of cyclic AMP in purified rat mast cells. II. Studies on the relationship between intracellular cyclic AMP concentrations and histamine release. J Immunol (1975) 1.52
Branch retinal artery occlusion in a child. Aust N Z J Ophthalmol (1996) 1.49
Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics. J Allergy Clin Immunol (1982) 1.48
Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur J Immunol (1998) 1.45
Analytic precision and accuracy of commercial immunoassays for specific IgE: establishing a standard. J Allergy Clin Immunol (2000) 1.44
Mutualistic asexual endophytes in a native grass are usually parasitic. Am Nat (2003) 1.44
Floppy eyelid syndrome and mental retardation. Ophthalmology (2000) 1.39
Skin testing to detect penicillin allergy. J Allergy Clin Immunol (1981) 1.37
Cardiac disorders in penicillin-induced anaphylaxis. Association with intravenous epinephrine therapy. JAMA (1982) 1.37
Regulators of cell division in plant tissue. XXIII. The identity of an unusual metabolite of 6-benzylaminopurine. Biochim Biophys Acta (1975) 1.36
Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med (1985) 1.36
Drug therapy. During allergy (third of three parts). N Engl J Med (1975) 1.36
Radioimmunoassay for the measurement of cyclic nucleotides. Adv Cyclic Nucleotide Res (1972) 1.29
Squamous cell carcinoma of the eyelids. Br J Ophthalmol (2002) 1.29
Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway. J Immunol (1979) 1.28
Primary localised amyloidosis of the orbit. Br J Ophthalmol (1996) 1.28
Modulation of cyclic AMP in purified rat mast cells. III. Studies on the effects of concanavalin A and anti-IgE on cyclic AMP concentrations during histamine release. J Immunol (1976) 1.26
Improved radioimaging and tumor localization with monoclonal F(ab')2. J Nucl Med (1983) 1.26
Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat Med (1996) 1.25
Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis. J Neuroimmunol (1997) 1.24
Raphanatin, an unusual purine derivative and a metabolite of zeatin. Biochem Biophys Res Commun (1972) 1.24
Possible role of arachidonic acid and its metabolites in mediator release from rat mast cells. J Immunol (1979) 1.23
Fluorescent probes for the study of the antibody-hapten reaction. I. Binding of the 5-dimethylaminonaphthalene-1-sulfonamido group by homologous rabbit antibody. Biochemistry (1967) 1.20
The preparation of nucleotide-protein conjugates: carbodiimides as coupling agents. J Immunol (1966) 1.18
Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes. J Exp Med (1983) 1.17
Correlation between mitogenicity and stimulation of calcium uptake in human lymphocytes. Biochem Biophys Res Commun (1974) 1.15
Concanavalin A-induced histamine release from normal rat mast cells. J Immunol (1975) 1.15
The intertrochanteric hip fracture. A retrospective analysis. Orthopedics (1988) 1.14
Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Ophthalmology (2000) 1.13
-Globulin binding of morphine in heroin addicts. J Lab Clin Med (1972) 1.13
Detection of Australia antigen by radioimmunoassay. Proc Natl Acad Sci U S A (1971) 1.13
The effect of Bordetella pertussis on lymphocyte cyclic AMP metabolism. J Exp Med (1973) 1.12
A method for detecting intracellular cyclic adenosine monophosphate by immunofluorescence. J Histochem Cytochem (1972) 1.12
Immunochemical studies with lysine vasopressin. Endocrinology (1966) 1.12
Monoclonal antibodies to immunoglobulin G4 induce histamine release from human basophils in vitro. J Allergy Clin Immunol (1982) 1.12
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism. Br J Cancer (2009) 1.12
Alterations in cyclic AMP metabolism in human bronchial asthma. 3. Leukocyte and lymphocyte responses to steroids. J Clin Invest (1973) 1.12
Selective cytotoxicity of hapten-substituted cells with an antibody-enzyme conjugate. J Immunol (1973) 1.11
Pathogenesis and management of allergic reactions to penicillin and other beta-lactam antibiotics. Pediatr Infect Dis (1983) 1.10
Diacylglycerol metabolism in mast cells: a potential role in membrane fusion and arachidonic acid release. J Exp Med (1979) 1.10
The rat basophilic leukemia cell receptor for IgE. I. Characterization as a glycoprotein. J Immunol (1976) 1.10
Hydrophobic binding sites on immunoglobulins. Biochemistry (1970) 1.10
The use of protein-substituted nylon catheters for selective immunoadsorption in vivo. J Immunol (1974) 1.08
12-L-hydroxy-5,8,10,14-eicosatetraenoic acid, a chemotactic fatty acid, is incorporated into neutrophil phospholipids and triglyceride. Prostaglandins (1979) 1.07
Opposing effects of mitogenic and nonmitogenic lectins on lymphocyte activation. Evidence that wheat germ agglutinin produces a negative signal. J Biol Chem (1976) 1.07
Cyclic AMP and the immune response;. Adv Cyclic Nucleotide Res (1974) 1.07
Prostaglandins and slow-reacting substance. J Allergy Clin Immunol (1979) 1.07
Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A-23187. Prostaglandins (1980) 1.06
Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. J Immunol (1986) 1.06
Modulation of macrophage C3b receptor function by cytochalasin-sensitive structures. J Immunol (1977) 1.05
Calcium stimulation of the 5-lipoxygenase from RBL-1 cells. Biochem Biophys Res Commun (1982) 1.05
Australasian orbital and adnexal Wegener's granulomatosis. Ophthalmology (2001) 1.05